Latest News & Features
Refine Search
Patents
 Agreement halts all litigation in multiple jurisdictions between the pair |  US company agrees to pay royalties to the Finnish telecoms giant for using video technology in its devices.   29 October 2024 
Copyright
 Member states cannot apply material reciprocity clause in Berne Convention following judgment | Decision relates to dispute over iconic Eames-designed chair   28 October 2024 
Patents
 A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 for the tech giant | Despite the victory, Masimo says the ruling does not apply to its current products.   28 October 2024 
Patents
 As India cements its position as one the world’s top innovators, the problem of inaccurate reports relating to IP needs to be addressed, warns Goutam Bhattacharyya of K&S Partners.   28 October 2024 
Patents
 Fed Circ’s decision allows Lenovo to challenge injunctions in Brazil and Colombia amid disputes over 5G patent licensing practices | Court asks for further examination of Ericsson’s compliance with FRAND standards.   25 October 2024 
Careers
 The firm has expanded its litigation team with the addition of Jonathan Sherman, a litigator known for his expertise in complex business disputes and First Amendment advocacy.   25 October 2024 
Trademarks
 Counsel from some of the world’s largest online retailers are working with sellers, police and international authorities to remove millions of fakes listings, reports Sarah Speight.   24 October 2024 
Trademarks
 Judges in Luxembourg uphold ruling restricting mark to headgear | Sports brand had hoped to extend protection to clothing, footwear and accessories.   24 October 2024 
Artificial Intelligence
 Disputes with AI start-ups used to revolve around copyright infringement but the tech's hallucinations have thrown trademarks into the mix, says William Stroever of Cole Schotz.   24 October 2024 
Patents
 European Supplementary Protection Certificates (SPCs) are very different to US PTEs in several key respects. In this seminar, we'll run through strategies to secure maximal protection for approved pharmaceutical & biologic products in Europe.   23 October 2024 
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.


